LARAE LYMER: Open Payments
NPI 1417327651 · ST CLOUD, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 12 payments from 10 companies in 2025. Trend: 2023 $93 · 2024 $225 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 2 | $153 |
| Abbott Laboratories | 2 | $71 |
| ENDOTRONIX, INC. | 1 | $64 |
| Alnylam Pharmaceuticals Inc. | 1 | $44 |
| Ancora Heart, Inc. | 1 | $35 |
| SCPHARMACEUTICALS INC. | 1 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Boston Scientific Corporation | 1 | $20 |
| AngioDynamics, Inc. | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
Products named: Barostim Neo System, CORDELLA PULOMONARY ARTERY PRESSURE SENSOR, CARDIOMEMS, AMVUTTRA, AccuCinch, FUROSCIX, UPTRAVI, THORATEC HEARTMATE 3 LVAS IMPLANT KIT.
Industry payments across MN — which companies pay providers there.
